These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36103974)

  • 81. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
    Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The role of PPARγ for the osteoblastic differentiation.
    Viccica G; Francucci CM; Marcocci C
    J Endocrinol Invest; 2010; 33(7 Suppl):9-12. PubMed ID: 20938219
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice.
    Fukui Y; Masui S; Osada S; Umesono K; Motojima K
    Diabetes; 2000 May; 49(5):759-67. PubMed ID: 10905484
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
    Hung SH; Yeh CH; Huang HT; Wu P; Ho ML; Chen CH; Wang C; Chao D; Wang GJ
    Life Sci; 2008 Mar; 82(11-12):561-9. PubMed ID: 18272184
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Different effects of thiazolidinediones on cardiovascular risk in patients with type 2 diabetes mellitus: pioglitazone versus rosiglitazone.
    Simó R; Rodriguez A; Caveda E
    Curr Drug Saf; 2010 Jul; 5(3):234-44. PubMed ID: 20210732
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Diuretics prevent thiazolidinedione-induced cardiac hypertrophy without compromising insulin-sensitizing effects in mice.
    Chang CS; Tsai PJ; Sung JM; Chen JY; Ho LC; Pandya K; Maeda N; Tsai YS
    Am J Pathol; 2014 Feb; 184(2):442-53. PubMed ID: 24287404
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of pioglitazone on transdifferentiation of preosteoblasts from rat bone mesenchymal stem cells into adipocytes.
    Wang L; Li L; Gao H; Li Y
    J Huazhong Univ Sci Technolog Med Sci; 2012 Aug; 32(4):530-533. PubMed ID: 22886965
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
    Zhao L; Li G; Chan KM; Wang Y; Tang PF
    Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes.
    Tedesco S; Ciciliot S; Menegazzo L; D'Anna M; Scattolini V; Cappellari R; Cignarella A; Avogaro A; Albiero M; Fadini GP
    Diabetes; 2020 Jul; 69(7):1562-1572. PubMed ID: 32345753
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Thiazolidinedione insulin sensitizers alter lipid bilayer properties and voltage-dependent sodium channel function: implications for drug discovery.
    Rusinova R; Herold KF; Sanford RL; Greathouse DV; Hemmings HC; Andersen OS
    J Gen Physiol; 2011 Aug; 138(2):249-70. PubMed ID: 21788612
    [TBL] [Abstract][Full Text] [Related]  

  • 93. SOD3 Is Secreted by Adipocytes and Mitigates High-Fat Diet-Induced Obesity, Inflammation, and Insulin Resistance.
    Gao D; Hu S; Zheng X; Lin W; Gao J; Chang K; Zhao D; Wang X; Zhou J; Lu S; Griffiths HR; Liu J
    Antioxid Redox Signal; 2020 Jan; 32(3):193-212. PubMed ID: 31680537
    [No Abstract]   [Full Text] [Related]  

  • 94. Vimentin protein is a factor for decreasing breast cancer cell proliferation co-culture with human bone marrow-derived mesenchymal stem cells pre-treated with thiazolidinedione solutions.
    Kwok LS; Yian SS; Ismael LQ; Bee YTG; Harn GL; Yin KB
    Mol Biol Rep; 2024 Feb; 51(1):317. PubMed ID: 38381204
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Oxylipin-PPARγ-initiated adipocyte senescence propagates secondary senescence in the bone marrow.
    Liu X; Gu Y; Kumar S; Amin S; Guo Q; Wang J; Fang CL; Cao X; Wan M
    Cell Metab; 2023 Apr; 35(4):667-684.e6. PubMed ID: 37019080
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Targeting adipocyte ESRRA promotes osteogenesis and vascular formation in adipocyte-rich bone marrow.
    Huang T; Lu Z; Wang Z; Cheng L; Gao L; Gao J; Zhang N; Geng CA; Zhao X; Wang H; Wong CW; Yeung KWK; Pan H; Lu WW; Guan M
    Nat Commun; 2024 May; 15(1):3769. PubMed ID: 38704393
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Constitutive bone marrow adipocytes suppress local bone formation.
    Li Z; Bagchi DP; Zhu J; Bowers E; Yu H; Hardij J; Mori H; Granger K; Skjaerlund J; Mandair G; Abrishami S; Singer K; Hankenson KD; Rosen CJ; MacDougald OA
    JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36048537
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Metformin increases bone marrow adipose tissue by promoting mesenchymal stromal cells apoptosis.
    Duan W; Zou H; Zang N; Ma D; Yang B; Zhu L
    Aging (Albany NY); 2023 Jan; 15(2):542-552. PubMed ID: 36645914
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Omega-3 PUFAs prevent bone impairment and bone marrow adiposity in mouse model of obesity.
    Benova A; Ferencakova M; Bardova K; Funda J; Prochazka J; Spoutil F; Cajka T; Dzubanova M; Balcaen T; Kerckhofs G; Willekens W; van Lenthe GH; Charyyeva A; Alquicer G; Pecinova A; Mracek T; Horakova O; Coupeau R; Hansen MS; Rossmeisl M; Kopecky J; Tencerova M
    Commun Biol; 2023 Oct; 6(1):1043. PubMed ID: 37833362
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease.
    Colca JR; Scherer PE
    Mol Metab; 2022 Jan; 55():101409. PubMed ID: 34863942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.